%0 Journal Article
%T Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report
%A Destin U. Lenz
%A Effie L. Crutcher
%A Elisa M. Greene
%J Journal of Pharmacy Practice
%@ 1531-1937
%D 2019
%R 10.1177/0897190017744421
%X Sexual dysfunction is a bothersome side effect of several medications, though it has not yet been reported with the use of ledipasvir/sofosbuvir for the treatment of hepatitis C. However, sexual dysfunction is a potentially unrecognized side effect of ledipasvir/sofosbuvir that could result in nonadherence and treatment failure. We report a case of a 42-year-old man with a sudden onset of sexual dysfunction with the initiation of ledipasvir/sofosbuvir for the treatment of hepatitis C. The patient had no prior history or risk factors for the development of sexual dysfunction. His symptoms resolved upon discontinuation of ledipasvir/sofosbuvir after a successful 12-week course. Clinicians should be aware that sexual dysfunction is a possible side effect of ledipasvir/sofosbuvir and educate patients appropriately. Adherence should be emphasized as the risks of untreated hepatitis C virus far outweigh transient sexual dysfunction
%K Harvoni£¿
%K hepatitis C virus
%K sexual dysfunction
%K ledipasvir/sofosbuvir
%U https://journals.sagepub.com/doi/full/10.1177/0897190017744421